Table 1.
Clinical characteristics of the groups with normal glucose tolerance and with prediabetes/type 2 diabetes
| Normal glucose tolerance (n = 155) | Prediabetes/diabetes (n = 184) | |
|---|---|---|
| Age (years) | 42.33 ± 14.23 | 51.61 ± 14.19* |
| Sex (M/F) | 50/105 | 96/88* |
| Systolic BP (mmHg) | 117.42 ± 14.42 | 128.88 ± 18.14* |
| Diastolic BP (mmHg) | 78.91 ± 8.88 | 83.96 ± 11.17* |
| BMI (kg/m2) | 24.79 ± 4.14 | 27.96 ± 4.59* |
| Waist circumference (cm) | 81.12 ± 11.25 | 91.06 ± 12.96* |
| Fasting plasma glucose (mg/dL) | 93.24 ± 4.53 | 106.16 ± 10.38* |
| Post-OGTT plasma glucose (mg/dL) | 107.29 ± 18.92 | 141.25 ± 41.93* |
| Fasting serum insulin (μIU/mL) | 9.71 ± 5.03 | 14.49 ± 9.19* |
| Post-OGTT serum insulin (μIU/mL) | 43.13 ± 28.42 | 82.92 ± 91.91* |
| Cholesterol (mg/dL) | 182.36 ± 37.64 | 190.34 ± 38.14 |
| Triglycerides (mg/dL) | 96.28 ± 60.19 | 118.01 ± 72.89* |
| HDL-cholesterol (mg/dL) | 63.05 ± 16.60 | 58.93 ± 14.17* |
| LDL-cholesterol (mg/dL) | 117.84 ± 32.37 | 127.10 ± 35.76* |
| HOMA-IR | 2.25 ± 1.20 | 3.88 ± 2.82* |
| QUICKI | 0.35 ± 0.02 | 0.32 ± 0.03* |
| Matsuda index | 6.21 ± 2.71 | 3.81 ± 2.28* |
| RBC (mln/μL) | 4.71 ± 0.46 | 4.83 ± 0.40* |
| AlAt (U/L) | 19.89 ± 11.67 | 25.06 ± 14.83* |
| C-peptide (pmol/mL) | 0.71 ± 0.22 | 0.92 ± 0.38* |
| SHBG (nmol/L) | 38.55 ± 25.79 | 30.44 ± 17.92* |
| Adiponectin (μg/mL) | 16.18 ± 9.29 | 10.05 ± 7.29* |
| IGFBP-1 (ng/mL) | 3.18 ± 2.70 | 2.12 ± 1.72* |
| FLAIS | 7.74 ± 1.59 | 6.64 ± 1.41* |
*p < 0.05 vs normal glucose tolerance